Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barohn

Showing results (301-310 of 345) with videos related to

Pageof 35
Sort By:
The Lancet. Neurology|November 6, 2007
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trialPaul H Gordon, Dan H Moore, Robert G Miller, et al.
Neuromuscular Disorders : NMD|February 17, 2019
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose studyLoren D M Pena, Richard J Barohn, Barry J Byrne, et al.
Neurology|February 27, 2001
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathyJ R Mendell, R J Barohn, M L Freimer, et al.
Neurology|May 26, 2022
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe DiseaseMazen M Dimachkie, Richard J Barohn, Barry Byrne, et al.
Annals of Neurology|June 3, 2010
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophyVinod Malik, Louise R Rodino-Klapac, Laurence Viollet, et al.
Neurobiology of Aging|February 12, 2015
The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositisQiang Gang, Conceicao Bettencourt, Pedro M Machado, et al.
Molecular Genetics and Metabolism|July 31, 2016
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY StudyAns van der Ploeg, Pierre G Carlier, Robert-Yves Carlier, et al.
Journal of Clinical and Translational Science|May 9, 2017
Education and training of clinical and translational study investigators and research coordinators: A competency-based approachNancy A Calvin-Naylor, Carolynn Thomas Jones, Michelle M Wartak, et al.
Neurology|April 11, 2001
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisR G Miller, D H Moore, D F Gelinas, et al.
Neurology|July 27, 2001
Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathyM Aoki, J Liu, I Richard, et al.
Pageof 35

Showing results (301-310 of 345) with videos related to

Sort By:
Pageof 35
The Lancet. Neurology|November 6, 2007
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trialPaul H Gordon, Dan H Moore, Robert G Miller, et al.
Neuromuscular Disorders : NMD|February 17, 2019
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naïve and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose studyLoren D M Pena, Richard J Barohn, Barry J Byrne, et al.
Neurology|February 27, 2001
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathyJ R Mendell, R J Barohn, M L Freimer, et al.
Neurology|May 26, 2022
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe DiseaseMazen M Dimachkie, Richard J Barohn, Barry Byrne, et al.
Annals of Neurology|June 3, 2010
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophyVinod Malik, Louise R Rodino-Klapac, Laurence Viollet, et al.
Neurobiology of Aging|February 12, 2015
The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositisQiang Gang, Conceicao Bettencourt, Pedro M Machado, et al.
Molecular Genetics and Metabolism|July 31, 2016
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY StudyAns van der Ploeg, Pierre G Carlier, Robert-Yves Carlier, et al.
Journal of Clinical and Translational Science|May 9, 2017
Education and training of clinical and translational study investigators and research coordinators: A competency-based approachNancy A Calvin-Naylor, Carolynn Thomas Jones, Michelle M Wartak, et al.
Neurology|April 11, 2001
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisR G Miller, D H Moore, D F Gelinas, et al.
Neurology|July 27, 2001
Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathyM Aoki, J Liu, I Richard, et al.
Pageof 35